Hair loss can be traumatic and, unfortunately, extremely common. But a New Jersey doctor says he has a new treatment.

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Research shows that promoting fruits and vegetables isn't enough to combat weight gain, highlighting the significant role of ...

Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday ...

Hims & Hers Health stock rocketed to a new all-time high Thursday as retail interest continued after its successful Super ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Hims recaps the year's most surprising health findings, from the growing number of adults who consider monogamy optional to those who would rather lose weight than be debt free.

Hims, Inc. is a telehealth company, primarily targets men's wellness and healthcare. The company offers treatments for issues like hair loss and erectile dysfunction. Hims leverages online ...

Hims & Hers’ continued focus on strengthening its comprehensive weight loss offerings ... by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can ...

While it doesn't directly stimulate new hair growth, it improves scalp conditions, reduces dryness, and strengthens hair follicles, creating an environment conducive to healthier, stronger hair ...

With all the talk surrounding the perks of weight loss medications right now, it’s fair to wonder if it’s possible to lose weight through other less traditional methods. Using red light ...

MSCI's fourth-quarter net income fell 24% as higher expenses and a tax gain in the year-earlier quarter offset revenue growth for the financial index firm. The New York-based data provider ...